
Keywords: دوکسوروبیسین; CDDP; cisplatin; GSH; reduced glutathione; MDA; malondialdehyde; NO; nitric oxide; cTn-I; cardiac troponin; PDE5; phosphodiesterase-5 enzyme; i.p.; intraperitoneally; cAMP; cyclic adenosine monophosphate; cGMP; cyclic guanosine monophosphate; CAD; coronar